Nova Health
NOVA HEALTHHome nursing and physiotherapy
Stroke · Gait retraining

Robotic Gait Training and Exoskeletons After Stroke: Do They Improve the Chance of Walking Again? Clinical Evidence and Cost-Effectiveness

In recent years, "exoskeleton robots" and "robotic legs" have appeared often in stroke rehabilitation advertisements and news reports. The pictures show patients wearing a mechanical device and walking forward step by step, like a scene from a science fiction film. Families naturally ask: can these devices help the patient walk again, and are they worth paying for? Robotic training is mostly self-paid and each session is costly, so families often have to make a decision in front of a large medical expense.

This article gives an objective analysis. It does not promote any equipment and does not follow trends. It uses the latest reliable clinical evidence to answer three questions: does robotic gait training or exoskeleton therapy help a patient walk again after stroke, which patients benefit most, and how cost-effective is it? In short, these devices are an add-on to conventional physiotherapy and do not replace it. They suit patients with specific conditions, and they are not worth using for every patient.

Summary: Using electromechanical-assisted gait training together with conventional physiotherapy (and not in place of it) can increase the chance that a stroke patient walks independently again. It has almost no practical effect on walking speed. The group that benefits most, and gets the best value, is patients with more severe stroke who cannot yet walk in the first 3 months after onset.

Clinical research results on robot-assisted gait training

The most reliable way to judge whether a treatment is worth using is to look at a systematic review that pools several randomised controlled trials. The Cochrane systematic review updated in 2025 (Mehrholz et al. 2025) examined the overall effect of electromechanical or robotic gait training combined with physiotherapy. Its conclusions are clear and also cautious:

OR 1.65
Chance of walking independently again
95% CI 1.21–2.25, moderate certainty of evidence; on average about 1 extra person in 9 treated regains independent walking (NNT≈9) (Mehrholz et al. 2025)
+0.05 m/s
Increase in walking speed
The practical clinical benefit is very small, and patients will not notice a clear difference when walking in daily life (Mehrholz et al. 2025).
+11 metres
6-minute walk distance
High certainty of evidence, and a moderate functional improvement (Mehrholz et al. 2025).

The main benefit to expect from robotic training is that it helps the patient to cross the threshold from being unable to walk to being able to walk, and so raises the chance of regaining independent walking. The current evidence does not support an expectation that walking speed will increase greatly. The Cochrane report also warns that the benefit may fade after the course ends and may not be maintained in the long term. It is therefore not a one-time cure. It is an aid for increasing training dose during the main recovery period.

Limits of the effect: A gain of 0.05 m/s in walking speed is almost impossible to feel in daily walking. The main use of robotic training is to help patients who cannot yet walk to take their first steps again. It is not meant to make people who can already walk go faster. Understanding this helps the family use resources according to the rehabilitation goal and set reasonable expectations.

Which patients benefit most from robotic training

Beyond the average effect for the whole group, subgroup analyses that show which patients gain most are more useful. An earlier Cochrane systematic review (Mehrholz et al. 2017) had already shown that the benefit is not evenly spread across all patients:

Within the first 3 months after onsetFrom the acute to the subacute phase of stroke, repair in the brain is at its most active. This is the main recovery period, and patients who receive robot-assisted gait training at this stage gain the most.
Not yet able to walk (non-ambulatory, FAC 0)Patients with more severe stroke who cannot walk show the clearest effect. When the patient cannot yet control the legs well enough, the machine can safely move the legs through many repeated walking cycles.

For chronic-stage patients who can already walk slowly, the current evidence does not show that robotic training is better than conventional training. For the neuroscience behind "most benefit in the first 3 months" (sensitive periods and neuroplasticity), see the page on the stroke recovery "golden period". For the stages of the whole recovery process, see the stroke recovery timeline. The best time to start robotic training matches the acute and subacute phases.

Patients can also be grouped by the degree of lower-limb impairment. Patients with more severe stroke who cannot yet walk and need a lot of help can read physiotherapy for the lower limb after severe stroke. Patients who can stand but still have difficulty walking can read physiotherapy for the lower limb after moderate stroke, which has specific training programmes for each level of severity.

Cost-effectiveness of robotic training

Robotic training is mostly self-paid and each session is expensive, so whether it is worth joining depends to a large extent on cost-effectiveness. A cost-effectiveness analysis in Singapore (Shankar et al. 2025) compared a robotic exoskeleton with conventional physiotherapy in inpatient rehabilitation patients in the acute to subacute phase (under 9 months). It also showed that patients should be sorted by their condition, and that the device should not be used for everyone:

ICER ≈ US$28,260/QALY
Severe patients with FAC 0
For patients with more severe stroke who cannot yet walk, this training has the best cost-effectiveness, and the cost is well below the commonly used threshold (Shankar et al. 2025).
All < US$50,000/QALY
Acute to subacute inpatient rehabilitation
At this stage, robotic training gave better value than conventional therapy alone in every patient group. In the chronic stage, conventional therapy gave better value (Shankar et al. 2025).

Based on the clinical evidence above, patients and families can use the following guide for a first assessment:

More worth considering robotic training
  • Acute or subacute phase in the first 3 months after onset
  • Patients with more severe stroke who cannot yet walk (FAC 0) and need a lot of help
  • Hospital or institutional rehabilitation, where a full course can be completed
  • The goal is to take the first independent steps again
Less likely to be worth it, so be cautious
  • Chronic-stage patients who can already walk slowly
  • Mild stroke with walking that is already largely independent
  • The only aim is to walk faster, which the evidence does not support
  • Putting resources into high-dose overground and functional training may be more practical

Choose the type of training according to actual need.If the patient's condition is mild, is already in the chronic stage, or the patient can already walk, spending the same resources on high-volume overground training close to daily life is usually better value. Whether a patient suits robotic training should be assessed by a physiotherapist according to severity, stage of recovery and goals, and the decision should not be based on advertising alone.

Comparing the two types of robotic equipment

Robotic walking systems on the market fall broadly into two types, and each has a different evidence base. The comparison below is objective and does not promote any particular model:

End-effector type (footplate type)

  • The patient stands with both feet on moving footplates, and the machine moves the feet in a walking pattern.
  • In subacute patients, this type of device gives a clearer improvement in walking speed.
  • Even if the patient cannot yet control the legs, the machine can move them through a large number of repeated cycles.

Exoskeleton type (wearable)

  • This is a mechanical frame worn on the legs. It follows each joint and gives powered assistance.
  • Overground exoskeletons mainly help walking speed. The improvement is small but statistically significant.
  • They usually give no clear extra benefit for balance (BBS), the Timed Up and Go test (TUG) or endurance (Lee et al. 2024).

The systematic review of overground exoskeletons (Lee et al. 2024) also found that these devices give limited extra help for balance and endurance, so one machine should not be expected to solve every functional problem. Improving balance and preventing falls needs a separate, specific programme, described in balance and fall-prevention training. Applying the regained walking ability to daily life (for example, arranging toilet use or going shopping) is the area of occupational therapy. Physiotherapy (PT) focuses on restoring the walking movement, and occupational therapy (OT) focuses on practical application in daily life. See occupational therapy after stroke for details.

Timing and frequency of robotic training

Another common misunderstanding is that "the more robotic training, the better". Evidence on overground exoskeletons (Lee et al. 2024) shows that the training parameters have an optimal balance, and that simply adding sessions does not produce a better effect:

A training schedule with better results (to be adjusted by the PT for each patient)
  • Each session lasts longer than 30 minutes, to give enough practice volume.
  • No more than 3 sessions a week, so the body has time to rest and adapt.
  • A course of about 4 weeks, concentrated in the effective rehabilitation window.
  • Do not simply add more sessions in the belief that more frequent training is always better.

The machine is only an aid for increasing training dose. What actually drives functional recovery is high-dose, task-based repetitive training, together with the physiotherapist's assessment of the individual patient and programme planning. Home self-help rehabilitation equipment is also at a different level from the clinic or institutional robotic gait systems. For equipment suited to use at home, see stroke rehabilitation equipment and aids.

Use resources according to the patient's situation.Robotic gait training is not a miracle treatment and cannot replace the physiotherapist's professional judgement. Its role is to help patients with more severe stroke who cannot yet walk to take steps again during the main recovery period, and to increase their practice volume. Because it helps mainly in particular situations, it gives the best value when used at the right time and with the right goal.

Frequently asked questions

Does robotic or exoskeleton gait training really help a patient walk again after stroke?
It does help, but expectations should be realistic. The 2025 Cochrane systematic review found that electromechanical-assisted gait training used together with conventional physiotherapy raises the chance of regaining independent walking after stroke (OR 1.65, moderate certainty of evidence; on average about 1 extra person in 9 treated regains independent walking). These devices are an addition to conventional treatment and do not replace it, and they do not produce fast results.
Does walking speed improve a lot after robotic training?
Expectations should stay modest. The same 2025 Cochrane evidence shows that walking speed increases by only about 0.05 m/s on average, which has very little clinical meaning and is hard to notice in daily walking. The 6-minute walk distance increases by about 11 metres, which is a moderate functional improvement. The chance of walking again goes up, but the gain in walking speed remains small.
Which stroke patients benefit most from robotic gait training?
The evidence best supports patients with more severe stroke who cannot yet walk (FAC 0) within the first 3 months after onset. In the 2025 Singapore cost-effectiveness analysis in BMJ Open, this group gained the most and the cost-effectiveness was highest. For chronic-stage patients who can already walk slowly, robotic training has not been shown to be better than conventional training, and conventional therapy is more cost-effective.
Robotic gait training versus conventional physiotherapy: which is better?
The two are not in competition. The best approach is to use robotic assistance together with conventional physiotherapy, and not in place of it. Functional recovery depends mainly on high-dose, task-based repetitive training. The machine is a tool for increasing training dose, and the physiotherapist's assessment and individual programme are still needed.
Is more frequent robotic training always better?
No. Research on overground exoskeletons suggests there is an optimal balance in training dose. The best results were seen with sessions longer than 30 minutes, no more than 3 times a week, over a course of about 4 weeks. Simply adding more sessions may not bring better results, and the intensity and frequency should be set by the physiotherapist for each patient.

Disclaimer: This article is general health information and is not professional medical advice. If you have any health concerns, please consult a qualified healthcare professional.

References

  1. Mehrholz, J., Kugler, J., Pohl, M., & Elsner, B. (2025). Electromechanical-assisted training for walking after stroke. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD006185.pub6 (PMID 40365867)
  2. Mehrholz, J., Thomas, S., Werner, C., Kugler, J., Pohl, M., & Elsner, B. (2017). Electromechanical-assisted training for walking after stroke. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD006185.pub4
  3. Lee, M. H., Tian, M. Y., & Kim, M. K. (2024). The effectiveness of overground robot exoskeleton gait training on gait outcomes, balance, and motor function in patients with stroke: A systematic review and meta-analysis of RCTs. Brain Sciences, 14(8), 834. https://doi.org/10.3390/brainsci14080834 (PMID 39199525)
  4. Shankar, R., Tang, N., Shafawati, N., Phan, P., Mukhopadhyay, A., & Chew, E. (2025). Cost-effectiveness analysis of robotic exoskeleton versus conventional physiotherapy for stroke rehabilitation in Singapore. BMJ Open. https://doi.org/10.1136/bmjopen-2024-095269 (PMID 40623888)